Skip to main content
Granicus logo

Granicus

Security and trust center evidence

Summary

Granicus has 2 registry-verified rows in the CertReports index, last verified 17 Sep 2026. The strongest row is FedRAMP: FedRAMP Authorized. This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.

Reviewer brief

As of 17 Sep 2026, Granicus is listed in the FedRAMP registry as FedRAMP Authorized, with an authorization issued 08 Apr 2016 and no expiration date recorded, audited by A-LIGN Compliance and Security, Inc. dba A-LIGN. As of 17 Sep 2026, Granicus is listed in the EU-US Data Privacy Framework registry as Active, covering both the EU-US Certification and UK Extension Certification, issued 16 May 2017 and expiring 15 Jan 2027. As of 17 Sep 2026, no public evidence found for SOC 2. As of 17 Sep 2026, no public evidence found for HIPAA. As of 17 Sep 2026, no public evidence found regarding subprocessors beyond a listed count of zero.

  • FedRAMP: listed in fedramp registry as FedRAMP Authorized, issued 08 Apr 2016, no expiration date, audited by A-LIGN Compliance and Security, Inc. dba A-LIGN (as of 17 Sep 2026)
  • EU-US Data Privacy Framework: listed in dpf registry as Active (EU-US Certification, UK Extension Certification), issued 16 May 2017, expires 15 Jan 2027 (as of 17 Sep 2026)
  • SOC 2 and HIPAA: no public evidence found (as of 17 Sep 2026)

Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 17 Sep 2026; it is regenerated whenever a row changes.

Among government and public sector vendors

2verified rows

Category median 1, across 19 indexed government and public sector vendors. Granicus has more verified rows than 100 percent of them.

citizen engagementcivic technologygovernment servicespublic sector platform

Compliance grid

Subprocessors

No subprocessor list captured yet.

Similar vendors with evidence

Related by product tags and the Government and public sector category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.